ATE128738T1 - Verfahren zum schnellen und empfindlichen nachweis von igm-antikörpern gegen retrovirale antigene. - Google Patents

Verfahren zum schnellen und empfindlichen nachweis von igm-antikörpern gegen retrovirale antigene.

Info

Publication number
ATE128738T1
ATE128738T1 AT88908063T AT88908063T ATE128738T1 AT E128738 T1 ATE128738 T1 AT E128738T1 AT 88908063 T AT88908063 T AT 88908063T AT 88908063 T AT88908063 T AT 88908063T AT E128738 T1 ATE128738 T1 AT E128738T1
Authority
AT
Austria
Prior art keywords
rapid
pct
antibodies against
sensitive detection
igm antibodies
Prior art date
Application number
AT88908063T
Other languages
English (en)
Inventor
Kurt B Osther
Louis M Dyll
Original Assignee
Verigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK362087A external-priority patent/DK362087D0/da
Priority claimed from DK362287A external-priority patent/DK362287D0/da
Application filed by Verigen Inc filed Critical Verigen Inc
Application granted granted Critical
Publication of ATE128738T1 publication Critical patent/ATE128738T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/805—Test papers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT88908063T 1987-07-13 1988-07-05 Verfahren zum schnellen und empfindlichen nachweis von igm-antikörpern gegen retrovirale antigene. ATE128738T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK362087A DK362087D0 (da) 1987-07-13 1987-07-13 Method for a rapid and sensitive detection of early appearing antibodies against retroviruses, as well as igg antibodies against certain retroviruses
DK362287A DK362287D0 (da) 1987-07-13 1987-07-13 Method for rapid and sensitive detection of hiv-1 antibodies

Publications (1)

Publication Number Publication Date
ATE128738T1 true ATE128738T1 (de) 1995-10-15

Family

ID=26067139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88908063T ATE128738T1 (de) 1987-07-13 1988-07-05 Verfahren zum schnellen und empfindlichen nachweis von igm-antikörpern gegen retrovirale antigene.

Country Status (7)

Country Link
US (1) US5093230A (de)
EP (1) EP0324849B1 (de)
AT (1) ATE128738T1 (de)
AU (1) AU2314088A (de)
CA (1) CA1296626C (de)
DE (1) DE3854553T2 (de)
WO (1) WO1989000609A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU635008B2 (en) * 1989-12-13 1993-03-11 Genelabs Diagnostics Pte Ltd Analytical apparatus and method for automated blot assay
EP0564460B1 (de) * 1990-08-16 1998-10-21 Diagnostic Biotechnology, Inc. Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
JP2760896B2 (ja) * 1991-04-11 1998-06-04 シーダーズ―サイナイ・メディカル・センター ＨＩＶ特異的ＩｇＭの検出のための免疫検定
US5547833A (en) * 1994-01-04 1996-08-20 Intracel Corporation Radial flow assay, delivering member, test kit, and methods
US5561045A (en) * 1994-01-04 1996-10-01 Intracel Corporation Detection reagent, article, and immunoassay method
AU2001295441A1 (en) * 2000-10-17 2002-04-29 Besst-Test Aps Assay for directly detecting a biological cell in a body fluid sample
US20020173053A1 (en) * 2001-04-27 2002-11-21 Bassam Damaj Multiple simultaneous antigen detection by immunohistochemistry
US20050214882A1 (en) * 2004-03-25 2005-09-29 Ez Bio Inc. Reagents, methods and kits for the universal rapid immuno-detection
DE102008030129A1 (de) 2008-06-27 2010-01-21 Prionics Ag Verfahren zur Bestimmung von Trichinella-Infektionen und diagnostische Zusammensetzung für solche Verfahren
EP2550362B1 (de) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv-glycoproteine und rekombinante vektoren
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
CN102621328B (zh) * 2012-03-14 2014-08-06 天津市南开医院 牛奶抗体谱诊断试剂盒
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452901A (en) * 1980-03-20 1984-06-05 Ciba-Geigy Corporation Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays
GB8501671D0 (en) * 1985-01-23 1985-02-27 Allen G J Immunoassay
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4918000A (en) * 1985-09-27 1990-04-17 Walter Schubert Multi-color labeling of different antigens in a biological system
US4816387A (en) * 1986-06-06 1989-03-28 Bio-Research Laboratories, Inc. Method for detection of antibodies to HTLV-III and diagnostic test kit useful therewith
DK362287D0 (da) * 1987-07-13 1987-07-13 Kurt Baekgaard Osther Method for rapid and sensitive detection of hiv-1 antibodies

Also Published As

Publication number Publication date
WO1989000609A1 (en) 1989-01-26
CA1296626C (en) 1992-03-03
DE3854553D1 (de) 1995-11-09
EP0324849A4 (en) 1992-05-06
US5093230A (en) 1992-03-03
DE3854553T2 (de) 1996-03-21
EP0324849A1 (de) 1989-07-26
EP0324849B1 (de) 1995-10-04
AU2314088A (en) 1989-02-13

Similar Documents

Publication Publication Date Title
ATE128738T1 (de) Verfahren zum schnellen und empfindlichen nachweis von igm-antikörpern gegen retrovirale antigene.
DE69126248D1 (de) Immunchromatographischer assay und verfahren zur nutzung desselben
ATE114672T1 (de) Peptidzusammensetzung und verfahren zum nachweis von antikörpern gegen htlv-iii.
ATE364621T1 (de) Hiv-peptide
NO870412D0 (no) Peptider.
ATE228248T1 (de) Verfahren zur simultanen bestimmung von hiv- antigenen und hiv-antikörpern
DE69332236D1 (de) Verfahren zur Dissoziierung von einem Immunokomplex und dafür verwendeter Immunoassay
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
SE9000595D0 (sv) New peptides, diagnostic antigens and an immunoassay method
ATE105086T1 (de) Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b.
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
DE69123723D1 (de) Diagnostisches verfahren und reagenz für hiv
ATE132268T1 (de) Immuntest zum gleichzeitigen nachweis von hiv-1, hiv-2, htlv-i und htlv-ii antikörpern
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ATE286596T1 (de) Chemische modifikation von antikörpern und antigenen
ATE134649T1 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
DK0674718T3 (da) Fremgangsmåde til identifikation af individer smittet med HIV og overvågning af deres terapi
ATE114818T1 (de) Immuntest zum nachweis von alpha-haloacetamiden.
ATE130050T1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.
ATE142342T1 (de) Benutzung von sp-2 monoklonalen antikörpern zur diagnostik und zur beobachtung des hiv- infektionsfortschritts

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee